Company: SXTPW
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-014334
Chunk: 2

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-02-14
Form: S-1
Chunk 2
---
”); (ii) 1,503,500 shares of our common stock issuable upon exercise of common warrants (the “February 2025 Common Warrants” and, together with the January 2025 Common Warrants, the “Common Warrants”) at an exercise price of $0.59 per share acquired by certain of the Selling Stockholders in the private placement that closed on February 6, 2025 (the “February 2025 Offering”); (iii) 76,616 shares of our common stock issuable upon exercise of warrants (the “January 2025 Placement Agent Warrants”) at an exercise price of $1.2763 per share acquired by the placement agent in the January 2025 Offering; and (iv) 112,763 shares of our common stock issuable upon exercise of warrants (the “February 2025 Placement Agent Warrants” and, together with the January 2025 Placement Agent Warrants, the “Placement Agent Warrants”) at an exercise price of $0.8938 per share acquired by the placement agent in the February 2025 Offering. Each Common Warrant was immediately exercisable upon the issuance date and will expire twenty-four months from the date of from issuance, and each Placement Agent Warrant was immediately exercisable upon the issuance date and will expire twenty-four months from the date of issuance. This prospectus also covers any additional shares of common stock that may become issuable upon any adjustment pursuant to the terms of the Common Warrants and the Placement Agent Warrants issued to the Selling Stockholders by reason of stock splits, stock dividends and other events described therein. The Selling Stockholders, or their respective transferees, pledgees, donees or other successors-in-interest, may sell the shares of common stock at prevailing market or privately negotiated prices, including in one or more transactions that may take place by ordinary broker’s transactions, privately negotiated transactions or through sales to one or more dealers for resale. The Selling Stockholders may sell any, all or none of the securities offered by this prospectus, and we do not know when or in what amount the Selling Stockholders may sell the shares underlying the Common Warrants and Placement Agent Warrants, as applicable, hereunder following the effective date of this registration statement of which this prospectus forms a part. We provide more information about how a Selling Stockholder may sell its shares in the section titled “ Plan of Distribution” on page 131 of this prospectus. We cannot predict when and in what amounts